FAGNX | RYVIX | FAGNX / RYVIX | |
Total Expense Ratio | 1.23 | 1.42 | 87% |
Annual Report Gross Expense Ratio | 1.23 | 1.45 | 85% |
Fund Existence | 37 years | 27 years | - |
Gain YTD | 3.853 | -12.147 | -32% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 897M | 4.86M | 18,468% |
Annual Yield % from dividends | 0.84 | 0.00 | - |
Returns for 1 year | -0.06 | -21.11 | 0% |
Returns for 3 years | 12.99 | -5.07 | -256% |
Returns for 5 years | 178.59 | 73.82 | 242% |
Returns for 10 years | 41.76 | -67.56 | -62% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RXD | 12.04 | 0.13 | +1.13% |
ProShares UltraShort Health Care | |||
TEI | 5.84 | -0.04 | -0.68% |
Templeton Emerging Markets Income Fund | |||
IHD | 5.72 | -0.06 | -1.04% |
VOYA EMERGING MARKETS HIGH Income DIVIDEND EQUITY FUND | |||
CHY | 10.48 | -0.15 | -1.41% |
Calamos Convertible and High Income Fund | |||
DFSV | 28.67 | -0.44 | -1.51% |
Dimensional US Small Cap Value ETF |